You are here

Emprendedores magazine recognises the global leadership of Bioiberica in the production of heparin

4 Aug 2021
  • Bioiberica produces 20% of the world's Heparin API.
  • Heparin saves around a hundred million lives every year.
  • One out of every 5 doses of heparin administered in the world comes from Bioiberica.

Emprendedores magazine and BBVA Momentum have recognised Bioiberica as a global Spanish company for its contribution to leadership in the production of heparin. 

Bioiberica's specialisation in the extraction and development of biomolecules makes us a world leader in the production of the active pharmaceutical ingredient (API) heparin, the main anticoagulant in the prevention and treatment of thrombosis. Heparin, deemed an essential medicine by the World Health Organization, was discovered in 1916 by Jay McLean, a young medical student at Johns Hopkins University in Baltimore (USA) and is currently the most widely used anticoagulant to prevent and treat thrombosis. According to the International Society on Thrombosis and Haemostasis (ISTH), one in four people in the world die from thrombosis-related causes.

Founded in 1975, Bioibérica is a global biopharmaceutical firm present in over 80 countries with its headquarters in Esplugues de Llobregat (Barcelona). In total, Bioiberica has nine production centres in Spain, Italy, Poland, Germany, USA and Brazil, run by a team of more than 450 professionals to offer a portfolio of over 100 products. Bioiberica is also a world leader in the research, production and sale of other animal-derived APIs, ingredients and compounds such as chondroitin sulphate, glucosamine, hyaluronic acid, native type II collagen and thyroid.

Bioiberica's systems guarantee the traceability and quality of its entire production.

The company is vertically integrated and therefore has complete control over the entire life of the product: from development and production to sales. It complies with the highest international standards that certify its commitment to quality, safety, the environment and corporate social responsibility. The company rigorously supervises the entire production process from start to finish, backed by the highest quality standards and international certifications.

For more information, see the full article here (in Spanish):

Visit the website:

Related News

28 Sep 2021

The 28th Symposium on Glycosaminoglycans, an internationally renowned scientific event focusing on glycosaminoglycans, will be sponsored by

2 Aug 2021
  • One of every 5 doses of heparine administered in the world comes from Bioiberica.
  • Several studies indicate that people hospitalized treated with anticoagulants, improved their chances of survival. 
1 Jul 2019
  • This online asset has a double aim: to offer information on the business unit, and to concentrate in a single place scientific, historical and general public information on heparin